---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-266161"
form_type: "8-K"
ticker: "MDXG"
cik: "0001376339"
company_name: "MIMEDX GROUP, INC."
filed_at: "2023-10-30T23:59:59+00:00"
generated_at: "2026-06-09T05:44:28.132505+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# MiMedx Q3 net sales up 20.7% to $81.7M, GAAP net income $8.5M, raises FY outlook

## Summary
- Q3 net sales $81.7M (+20.7% YoY); GAAP net income $8.5M vs loss $8.4M prior year.
- Adjusted EBITDA $17.6M (21.6% margin) vs $2.4M; cash from ops $12.8M.
- Raised FY2023 net sales growth outlook to high teens; expects H2 Adj. EBITDA margin >20%.
- Repurchased $9.5M of Series B Preferred Stock from Hayfin; one-year lock-up.
- Cash $81.2M, up from $66.0M at Dec 31, 2022; long-term debt $49.0M.

## SEC filing metadata
- accession: 0001193125-23-266161
- form_type: 8-K
- ticker: MDXG
- cik: 0001376339
- company_name: MIMEDX GROUP, INC.
- filed_at: 2023-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1376339/000119312523266161/0001193125-23-266161-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1376339/000119312523266161/d570687d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-266161
- JSON: https://secwatch.observer/filing/0001193125-23-266161.json
- Plain text: https://secwatch.observer/filing/0001193125-23-266161.txt

## Key facts
- Earnings Releases
  MIMEDX GROUP, INC. reported the third quarter ended September 30, 2023 results: revenue $81.7 million, net income $8.5 million. Guidance raised.
  - Period: the third quarter ended September 30, 2023
  - Revenue: $81.7 million
  - Net income: $8.5 million
  - Guidance: raised
  - Result: reported results
  source text: operating and financial results for the third quarter 2023, which ended September 30, 2023. Recent Operating and Financial Highlights: • Third quarter 2023 net sales of $81.7 million, an increase of 20.7% over third quarter 2022. • GAAP net income of $8.5 million for third quarter 2023. • Adjusted EBITDA 1 of $17.6 million for third quarter 2023, representing
  evidence_url: https://www.sec.gov/Archives/edgar/data/1376339/000119312523266161/0001193125-23-266161-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.